CIK 0000876343 · Non-accelerated filer<br>Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 943127919
- Phone
- 5105213390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Jayasuriya Anula Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-07-01 | ANDREWS DEBORAH J Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-07-01 | Amin Dipti Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2026-07-01 | Bradsher Neal C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +125,000 | 125,000 | ||
| 2026-03-12 | Culley Brian M President and CEO | Purchase | +15,000 | $1.63 | $24K | 255,516 |
| 2026-03-05 | Culley Brian M President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +3,250,000 | 3,250,000 | ||
| 2026-03-05 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +1,050,000 | 1,050,000 | ||
| 2026-03-05 | Samuel George A. III General Counsel and Secretary | Grant or award · Employee Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2026-02-11 | Culley Brian M President and CEO | Option exercise | +31,250 | 253,385 | ||
| 2026-02-11 | Culley Brian M President and CEO | Shares withheld for taxes | −12,869 | $1.80 | $23K | 240,516 |
| 2026-02-11 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −31,250 | 0 | ||
| 2026-02-11 | Samuel George A. III General Counsel and Secretary | Option exercise | +6,075 | 33,565 | ||
| 2026-02-11 | Samuel George A. III General Counsel and Secretary | Shares withheld for taxes | −2,502 | $1.80 | $5K | 31,063 |
| 2026-02-11 | Samuel George A. III General Counsel and Secretary | Option exercise · Restricted Stock Units | −6,075 | 0 | ||
| 2025-12-19 | Culley Brian M President and CEO | Grant or award | +8,925 | 222,469 | ||
| 2025-12-19 | Culley Brian M President and CEO | Shares withheld for taxes | −334 | $1.68 | $561 | 222,135 |
| 2025-12-19 | Samuel George A. III General Counsel and Secretary | Grant or award | +1,735 | 27,555 | ||
| 2025-12-19 | Samuel George A. III General Counsel and Secretary | Shares withheld for taxes | −65 | $1.68 | $109 | 27,490 |
Page 1 of 8 · 153 trades